Blog
RSS FeedPosted by Michael Wonder on 23 Jun 2022
Calls to expand access to oral COVID-19 drugs as expiry dates loom
23 June 2022 - Thousands of doses of expensive anti-viral drugs could be wasted if more Australians do not become ...
Posted by Michael Wonder on 22 Jun 2022
New $11 million winter vaccine communication campaign and availability of antivirals
22 June 2022 - The Australian Government today launched an $11 million six-week campaign to encourage people to get vaccinated for ...
Posted by Michael Wonder on 19 Jun 2022
Current issues in health technology assessment of cancer therapies: a survey of stakeholders and opinion leaders in Australia
17 June 2022 - The aim of this study was to find ways of bridging the gap in opinions concerning health ...
Posted by Michael Wonder on 17 Jun 2022
Outcomes of the May 2022 PBAC intracycle meeting
17 June 2022 - The outcomes from the May 2022 PBAC meeting are now available. ...
Posted by Michael Wonder on 17 Jun 2022
Public consultation: draft 2022-23 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP
17 June 2022 - Consultation on the content of the draft 2022-23 Cost Recovery Implementation Statement (CRIS) for listing medicines ...
Posted by Michael Wonder on 16 Jun 2022
Pharmaceutical Benefits Scheme Safety Net threshold reduction from 1 July 2022
16 June 2022 - As a cost of living measure, the Australian Government is lowering the PBS Safety Net thresholds ...
Posted by Michael Wonder on 15 Jun 2022
Calls for 'blockbuster' osteoporosis drug to be made widely available
14 June 2022 - Experts want to see a new "blockbuster" drug made accessible for more patients suffering from osteoporosis. ...
Posted by Michael Wonder on 13 Jun 2022
Medicines Australia moves quickly to put HTA system reform high on new Government’s agenda
10 June 2022 - Medicines Australia has moved quickly to ensure that major reform of Australia’s health technology assessment system ...
Posted by Michael Wonder on 08 Jun 2022
Updated price disclosure guidelines, price disclosure webpages and price disclosure dispute resolution process
8 June 2022 - Amendments made to the National Health Act 1953 and National Health (Pharmaceutical Benefits) Regulations 2017 by the ...
Posted by Michael Wonder on 31 May 2022
Schedule of Pharmaceutical Benefits - 1 June 2022
1 June 2022 - The June 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 May 2022
Health insurance faces handbrake under Labor: UBS
30 May 2022 - A rebound in the number of Australians taking out private health insurance may slow under Labor’s ...
Posted by Michael Wonder on 30 May 2022
2022 Biosimilar Awareness Week: 30 May – 3 June
30 May 2022 - Marking a new dawn in medicine choice and affordability. ...
Posted by Michael Wonder on 25 May 2022
Remake of National Health (Supply of Pharmaceutical Benefits – Under Co-payment Data and Claims for Payment) Rules 2022
25 May 2022 - The Department has recently remade the National Health (Claims and under co-payment data) Rules 2012, now ...
Posted by Michael Wonder on 25 May 2022
Review of discount rate in the PBAC Guidelines
25 May 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment ...
Posted by Michael Wonder on 24 May 2022
Medicines Australia ready to work with new Government on medicines reform and life sciences
23 May 2022 - Medicines Australia congratulates Anthony Albanese and the Labor Party on their election win and forming Government. ...